Similar articles

• Laboratory indices in clofibrate therapy of juvenile-onset diabetes.

  Narduzzi JV, Danowski TS, Weir TF, Alley RA, Vester JW, Moses C. Narduzzi JV, et al. Clin Pharmacol Ther. 1967 Nov-Dec;8(6):817-23. doi: 10.1002/cpt196786817. Clin Pharmacol Ther. 1967. PMID: 4862480 Clinical Trial. No abstract available.
• Effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) and of clofibrate on the lipids of normal and hypercholesteremic rats.

  Berger FM, Douglas JF, Lu GG, Ludwig BJ. Berger FM, et al. Proc Soc Exp Biol Med. 1969 Oct;132(1):293-7. doi: 10.3181/00379727-132-34200. Proc Soc Exp Biol Med. 1969. PMID: 5344849 No abstract available.
• [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].

  Keller L, Rétsági G, Sebestyén M, Diczendy S, Erdélyi G. Keller L, et al. Z Gesamte Inn Med. 1966 Mar 15;21(6):169-72. Z Gesamte Inn Med. 1966. PMID: 5988081 German. No abstract available.
• Blood lipids and lipoproteins in atherogenesis.

  Brown DF. Brown DF. Am J Med. 1969 May;46(5):691-704. doi: 10.1016/0002-9343(69)90021-7. Am J Med. 1969. PMID: 4892338 Review. No abstract available.
• [Effect of Atromid on blood lipids in patients with hyperlipemia].

  Baranova LV. Baranova LV. Ter Arkh. 1968 Mar;40(3):15-20. Ter Arkh. 1968. PMID: 4875984 Review. Russian. No abstract available.